29 /100
MEDIUM RISK
Score updated Jun 02, 2026

CTOR — Citius Oncology, Inc. Dilution Risk Tracker

Track CTOR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CTOR — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
75
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.80 below $1 exchange minimum
🔔 Track CTOR — Get forecast alerts →

💹 Market Data

Market Cap$74.20M
Shares Outstanding92.98M
Float14.88M
Cash$2.63M
Debt$3.80M
Short InterestN/A

🏛 Institutional Holdings

15.3% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track CTOR for full holder detail →

📉 Short Interest

Short Interest484.3K
Days to Cover4.5
% of Float3.2%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 10, 2025
EFFECT EFFECT Mar 02, 2026
EFFECT EFFECT Jan 12, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track CTOR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CTOR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ACIU AGMB ALH ALOY AREN
🔬 More Research for CTOR
📊 CTOR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CTOR Signal Convergence & Dark Pool Activity — StonkWhisper 📄 CTOR Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.